These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Serious liver disease in a patient receiving methotrexate and leflunomide. Weinblatt ME; Dixon JA; Falchuk KR Arthritis Rheum; 2000 Nov; 43(11):2609-11. PubMed ID: 11083289 [No Abstract] [Full Text] [Related]
14. Oral mucositis in patients receiving low-dose methotrexate therapy for rheumatoid arthritis: report of 2 cases and literature review. Troeltzsch M; von Blohn G; Kriegelstein S; Woodlock T; Gassling V; Berndt R; Troeltzsch M Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 May; 115(5):e28-33. PubMed ID: 23601229 [TBL] [Abstract][Full Text] [Related]
15. Toxic epidermal necrolysis due to therapy with cyclophosphamide and mesna. A case report of a patient with seronegative rheumatoid arthritis and rheumatoid vasculitis. Chowdhury AC; Misra DP; Patro PS; Agarwal V Z Rheumatol; 2016 Mar; 75(2):200-2. PubMed ID: 26555550 [TBL] [Abstract][Full Text] [Related]
19. Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis. Wegrzyn J; Adeleine P; Miossec P Ann Rheum Dis; 2004 Oct; 63(10):1232-4. PubMed ID: 15361377 [TBL] [Abstract][Full Text] [Related]
20. Purpura fulminans from meningococcemia mimicking Stevens-Johnson syndrome in an adult patient taking etanercept. Gunawardane ND; Menon K; Guitart J; Cotliar JA Arch Dermatol; 2012 Dec; 148(12):1429-31. PubMed ID: 23247497 [No Abstract] [Full Text] [Related] [Next] [New Search]